Toluene sulfonamide-containing anti-tumor composition and method of use thereof
AssigneePTS International, Inc.
InventorsJohn Y. J. Wu, Rocky C. S. Shih, Lester J. Wu
Life of this patent
Estimating the term…
Abstract
The invention relates to compositions which exhibit anti-tumor activity and which comprise a toluene sulfonamide at a concentration not previously recognized as being efficacious for this purpose. The compositions exhibit the ability to inhibit tumor growth, shrink (i.e., necrotize) tumors, and prevent tumor formation in humans. The invention also includes methods of making and using the compositions.
Claims28
A pharmaceutical composition exhibiting anti-tumor activity, the composition comprising less than 10%, by weight, of a toluene sulfonamide and a pharmaceutically acceptable aqueous carrier selected from the group consisting of an injectable carrier, an infusible carrier and a palatable, orally-administrable carrier.
A method of making a pharmaceutical composition exhibiting anti-tumor activity, the method comprising combining a toluene sulfonamide and a pharmaceutically acceptable aqueous carrier to form the composition, wherein the carrier is selected from the group consisting of an injectable carrier, an infusible carrier and a palatable, orally-administrable carrier, and wherein the composition comprises less than 10% by weight of the toluene sulfonamide.
A method of inhibiting growth of a tumor in a human patient, the method comprising administering to the patient an aqueous pharmaceutical composition comprising less than 10%, by weight, of a toluene sulfonamide, thereby inhibiting growth of the tumor.
A method of shrinking a tumor in a human patient, the method comprising administering to the patient an aqueous pharmaceutical composition comprising less than 10%, by weight, of a toluene sulfonamide, thereby shrinking the tumor.
A method of preventing a tumor in a human patient at risk for developing a tumor, the method comprising administering to the patient an aqueous pharmaceutical composition comprising less than 10%, by weight, of a toluene sulfonamide, thereby preventing development of the tumor.
A palatable, aqueous anti-tumor pharmaceutical composition formulated for oral administration to a patient, the composition comprising less than 10%, by weight, of a toluene sulfonamide.
Dependencies are inferred from the claim text.